The Caribbean Public Health Agency (CARPHA) is pleased to invite you to its 66th Annual Health Research Conference. Under the theme COVID-19 and Digital Health: Transforming, Connecting, Informing Public Health, the event includes an action-packed agenda, and sessions with renowned keynote speakers. This year the Conference will be convened in a hybrid setting, embracing a face-to-face format as well as an interactive online component. Using a hybrid format, means there is no limit to the audience capacity, and we expect a significantly greater than usual number of registrants. This format offers an extended reach allowing persons from all corners of the world to participate. The conference and associated meetings/events have attracted over 200 regional and international delegates and meeting attendees in previous in-person formats, and a similar number of persons were in attendance during the first ever virtual conference held in 2021.
The conference is a great opportunity to engage delegates from across the Caribbean and beyond. The audience includes:
The Annual Health Research Conference is the largest health research conference in the English-speaking Caribbean. It is also the longest running health research Conference in the Latin America and the Caribbean (LAC) region with the first conference being held in 1957.
Sponsoring and/or exhibiting at CARPHA's Health Research Conference 2022 offers your organisation the opportunity to be involved with an important event to highlight public health concerns, projects, and achievements.
The Conference is an excellent networking opportunity for
We invite you to join us this year.
Take this opportunity to network and promote your brand and ideas.
Sponsorship or exhibiting at the Conference offers you the opportunity to:
Early confirmation of your sponsorship and/or exhibition will ensure an even higher level of exposure.
The conference will be promoted via emails, the CARPHA website, the conference websites, CARPHA social media platforms and is already mentioned at regional and international meetings with stakeholders. The conference app will be used for pre, during and post conference information.
The conference will combine a live in-person event with a virtual online component.
Depending on the restrictions at the time of the conference, delegates will have the option of attending the conference in Jamaica or participating virtually.
Face-to-face delegates will have access to all of the content present in the venue as well as the virtual on demand content. Virtual delegates will have access to and be able to participate in the sessions and view the content on demand.
Conference presentations, keynote addresses, exhibitor stands will be available 1 month after the event on the virtual platform.
Presenters and keynote speakers will present live at the venue and sessions will be broadcast through the virtual platform. Sessions will also be recorded and made available on demand through the virtual portal.
The virtual portal will be available to registered delegates for 1 month following the conference dates, to catch up on any presentations you have missed.
COVID-19 protocols will apply, in the event that there has to be cessation of in person gathering. If there is, then the hybrid conference will be pivoted to a virtual only conference. This would mean that the conference would not proceed with the face-toface component and all delegates will access the content through the virtual portal.
If the conference pivots to a virtual only conference, some packages entitlements may change.
Delegates, sponsors and exhibitors will be kept updated throughout the planning process and will be advised on how the conference will proceed depending on the restrictions.
This is a rare opportunity to engage face-to-face and virtually with attendees. Attendees can visit, and interact with exhibitors in the exhibition area, as well as the virtual conference portal. Even if the virtual Exhibition Hall is not open, attendees can still visit and view exhibitor profiles and download brochures outside of opening hours.
Network and connect with public health professionals to develop new relationships and strengthen existing ones.
Showcase your latest products and services to professionals in the health and allied health community
Potential to grow your market share - increase engagement with key decision makers
Communicate with delegates and decision makers to discuss business ideas and potential collaborations
In her current role, Ms. Pace is responsible for advancing the U.S. international health agenda through multilateral and bilateral forums. Reporting directly to the Secretary of Health & Human Services (HHS), she is the Office of Global Affairs’ lead on setting priorities and policies that promote American public health agencies and interests worldwide.
Ms. Pace oversees HHS’ engagement with foreign governments and international institutions as well policymaking bodies such as the G7, G20, United Nations General Assembly (UNGA), and World Health Assembly. Previously, she served as President & Executive Director of Global Health Council (GHC) and was also a member of the Biden-Harris Transition COVID-19 Advisory Board. At GHC, she advocated for increased federal investments in global health, in the face of budget cuts to the U.S. Centers for Disease Control & Prevention, United States Agency for International Development, and World Health Organization (WHO).
Prior to her role at GHC, Ms. Pace spent over a decade working with community-based organizations and grassroots leaders in countries across Africa and Asia on campaigns calling for person-centered access to health. Additionally, she has held positions on various global and regional advisory committees and boards that focus on equity and inclusion. Ms. Pace holds a Bachelor’s degree with Honors in human biology from Stanford University and a Master’s degree in international health & human rights with the distinction of Delta Omega from Johns Hopkins Bloomberg School of Public Health.
Dr St John rose in the ranks of Public Health in Barbados from 1994 to become the first Barbadian
Chief Medical Officer of Barbados in 2005. She represented Barbados on the Executive Board of
WHO, becoming the first Caribbean chairperson of the Executive Board in 2012-2013.
In 2017 she became Assistant Director General at the WHO HQ in Switzerland. She held the Portfolio of Climate and Other Determinants of Health and completed the first phase of the Climate Change and Health SIDS Initiative.
In July 2019 she became Executive Director of the Caribbean Public Health Agency. CARPHA led the CARICOM regional public health response to the COVID-19 pandemic. Her leadership has seen her engage about COVID-19 with several sectors in and outside of CARICOM.
Topic: “Empowering local health care professionals to improve cure rates in children with cancer and blood disorders in the Caribbean: Lessons from the SickKids-Caribbean Initiative (SCI)”.
Dr Victor Blanchette is Professor of Pediatrics, University of Toronto, Canada. He is a Staff Pediatric Hematologist in the Division of Hematology/Oncology and a Senior Associate Scientist (Emeritus) in the Research Institute at the Hospital for Sick Children, Toronto. He is the McCaig Magee Family Honorary Medical Director of the SickKids-Caribbean Cancer and Blood Disorders Initiative in the Centre for Global Child Health at the Hospital for Sick Children.
After completing his medical training at the University of Cambridge and St Bartholomew's Hospital in the United Kingdom, Dr Blanchette pursued subspecialty training in pediatrics at Johns Hopkins Hospital in Baltimore, USA followed by fellowship training in pediatric hematology/oncology at McMaster University Medical Centre in Hamilton, Canada.
Dr Blanchette's research interests are in the area of the congenital and acquired bleeding disorders of children. He is Co-Director of the Pediatric Comprehensive Care Hemophilia Program at the Hospital for Sick Children, and Chair of the International Prophylaxis Study Group (IPSG). Dr. Blanchette is recipient of the Canadian Pediatric Society 2009 Alan Ross Award, the Canadian Blood Services 2010 Lifetime Achievement Award, the American Society of Pediatric Hematology/Oncology 2012 Distinguished Career Award, the 2018 University of the West Indies (UWI) Vice-Chancellor’s Award, the 2019 Hemostasis and Thrombosis Research Society (HTRS) Lifetime Achievement Award and the 2019 Canadian Hematology Society (CHS) Lifetime Achievement Award. In 2018 Dr. Blanchette was awarded the Order of Barbados (Silver Crown of Merit), the country of his birth, for his contributions to the field of medicine. Dr Blanchette is an elected Fellow of the Royal College of Physicians and Surgeons of the United Kingdom.
Seeromanie Harding is Professor of Social Epidemiology at King’s College London. Her research focuses on inequalities in health over the life course, and participatory approaches to systems perspectives to engage with the complex socio-cultural-political contexts that drive health inequities. UK-based studies include those in London that are exploring how hairdressing salons and primary care can jointly promote early detection of cardiovascular disease and breast cancer among women living in deprived and ethnically dense neighbourhoods, the Healthy Eating and Active Lifestyles for Diabetes (HEAL-D) study in African and Caribbean communities, and the eLIXIR programme that links information from routine health records and blood samples from mothers and their children to explores the early origins of physical and mental health disorders. International studies include the CONTACT (Congregations Taking Action Against Non-Communicable Diseases) study in the Caribbean, the Health Kiosks in community Markets (HEKIMA) study in Kenya and the Xunati Uti study in Brazil. These studies explore the embedding of community systems (e.g., places of worship, community markets, schools) into the primary care pathway for prevention and control of non-communicable diseases. Before joining King’s College, she led the Medical Research Council Ethnicity and Health Research Programme at the University of Glasgow. Whilst there she established the Determinants of Adolescent, now young Adults, Social well-being and Health (DASH) study, a London based longitudinal study of ~6000 ethnically diverse young people. Equity, interdisciplinarity and collaborative partnerships with communities, policy actors and practitioners are key anchors in these studies. She is Head of the Department of Population Health Sciences at King’s College London, based within the Faculty of Life Sciences & Medicine, School of Life Course & Population Sciences. Population health research is led by over 160 experts, with patients and the public, to better understand how we can improve population health. Strong interdisciplinary research groups of social scientists, clinicians, health informaticists, statisticians and health economists, capacity building of early career researchers, and global health are key strengths of the Department
Dr Hospedales is a citizen of Trinidad and Tobago with over 30 years’ experience in public heath, facing many epidemics and pandemics. A lover of nature, a person of faith, a father and grandfather, Dr Hospedales founded EarthMedic and EarthNurse to mobilise health professionals to address the climate crisis.
He chairs the Defeat-NCD Partnership executive committee, addressing NCDs in low-resource countries; and is the Climate and Health Advisor to the Healthy Caribbean Coalition.
He was inaugural Director of the Caribbean Public Health Agency, and Coordinator Chronic disease prevention and control in PAHO/WHO.
He played a key role in the 2007 CARICOM Heads of Government Summit on NCDs, leading to the UN High Level meetings on NCDs in 2012, ’14 and ’18.
Honours graduate of UWI in medicine; MPH from London School of Hygiene and Tropical Medicine; Fellow, UK Faculty of Public Health, Dr Hospedales has published more than 100 papers and writes for the G7/G20 on climate and health.
Joann currently leads the Beyond Connectivity Initiative at TM Forum, helping our members to derisk their diversification strategy and grow their business beyond connectivity into new industry verticals such as enablement of connected healthcare and digital transformation of manufacturing.
She is a transformative technology leader who has led the development of two of the most successful areas of TM Forum, Open APIs and Business Architecture. The Open APIs from concept to global adoption in the Telecommunications industry and the Business Architecture methodology as the pivotal framework to enable capability driven CSP diversification for growth into and beyond new market opportunities.
Joann is a proven technology leader, with over 25 years industry experience, initially in consumer electronics and subsequently in Telecommunications working at both network and OSS/BSS architectural layers. Joann is TM Forum’s representative on Global Industry Organisations (GIO), leading the eHealth (Pandemic) focused initiative and represents TM Forum on NGIoT, Next Generation IoT and advisory board to the European Union. Joann also leads TM Forum’s representation in the 5GEM, Enabled Manufacturing project, a consortium lead by Ford Motor Car and Vodafone. Joann graduated with first class honors, BSc in Information Technology majoring in Telecommunications from Dublin City University and MBA from Open University.